|

Aspirin Clinical Trials

18 actively recruiting trials across 3 locations

▲ +1 trial since July 2026

Also known as: ASPIRIN® tablets, Acetylsalicylic Acid, Aspirin (drug), Aspirin Enteric-coated Tablets, Bayaspirin +4 more

Pipeline

Phase 2: 1Phase 3: 2Phase 4: 13Phase 2/3: 1

Top Sponsors

  • Yale University1
  • University Hospital, Bordeaux1
  • Takeshi Morimoto1
  • Shanghai Zhongshan Hospital1
  • Seoul National University Bundang Hospital1

Indications

  • Heart Disease16
  • Atrial Fibrillation4
  • Coronary Artery Disease4
  • Acute Coronary Syndrome2
  • Cardiovascular Diseases2

Other15 trials

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Phase 4
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
Phase 4
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Phase 4
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Phase 3
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Phase 4
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Phase 4
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Phase 4
IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
Phase 4
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Phase 4
Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Phase 4
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Phase 2/3
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
N/A
Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Phase 4
Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent
Phase 4
Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
Phase 4

Birmingham, Alabama1 trial

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

University of Alabama Hospital

Phase 3

Chicago, Illinois1 trial

Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

University of Chicago

Phase 4

Houston, Texas1 trial

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.